Acworth Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Acworth Pharmaceuticals has a total of 8 patents globally. Out of these 8 patents, more than 87% patents are active. The United States of America seems to be the main focused R&D center and also the origin country of Acworth Pharmaceuticals.

Acworth Pharmaceuticals was founded in the year 2018. Biotechnology Company Acworth Pharmaceuticals specializes in preclinical development for cancer treatment. Using its platform, the company is finding and creating direct-acting regulators that allow signaling pathways disrupted by cancer to resume their normal recycling function. The loss of essential components that kickstart the recycling process compromises the ability of dysregulated signaling molecules to return to a normal state within the cell in many cancers.

Do read about some of the most popular patents of Acworth Pharmaceuticals which have been covered by us in this article and also you can find Acworth Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Acworth Pharmaceuticals patent portfolio.

How many patents does Acworth Pharmaceuticals have?

Acworth Pharmaceuticals has a total of 8 patents globally. These patents belong to 1 unique patent families. Out of 8 patents, 7 patents are active.

How Many Patents did Acworth Pharmaceuticals File Every Year?

Acworth Pharmaceuticals Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAcworth Pharmaceuticals Applications FiledAcworth Pharmaceuticals Patents Granted

How many Acworth Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Acworth Pharmaceuticals Patents Portfolio

How Many Patents did Acworth Pharmaceuticals File in Different Countries?

Acworth Pharmaceuticals Worldwide Patents

Countries in which Acworth Pharmaceuticals Filed Patents

New Zealand1
United States Of America1

Where are Research Centers of Acworth Pharmaceuticals Patents Located?

The Research Centre for all the Acworth Pharmaceuticals patents is the United States of America.

What Percentage of Acworth Pharmaceuticals US Patent Applications were Granted?

Acworth Pharmaceuticals (Excluding its subsidiaries) has filed 1 patent application at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Acworth Pharmaceuticals’ patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Acworth Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Elmore Patent Law Group Pc10%

List of Acworth Pharmaceuticals Patents

Acworth PharmaceuticalsTitle
US20220332793A1Peptide Mimetics Of Dkk3B And Methods Of Use
EP4051306A1Peptide Mimetics Of Dkk3B And Methods Of Use
CN114929255APeptidomimetics Of Dkk3B And Methods Of Use
CA3155322A1Peptide Mimetics Of Dkk3B And Methods Of Use
AU2020373011A1Peptide Mimetics Of Dkk3B And Methods Of Use
JP2023501947APeptidomimetics Of Dkk3B And Methods Of Use
NZ787495APeptide Mimetics Of Dkk3B And Methods Of Use
WO2021087031A1Peptide Mimetics Of Dkk3B And Methods Of Use

What are Acworth Pharmaceuticals’ key innovation segments?

What Technologies are Covered by Acworth Pharmaceuticals?

The chart below distributes patents filed by Acworth Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Acworth Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Acworth Pharmaceuticals search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Acworth Pharmaceuticals?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.